Biopreservation relates to expanded lifespan and increased food safety by using artificial microflora and their antibacterial products. Lactic acid bacteria have great ability to be used in Biopreservation because they are secure to eat and they dominate many products ‘ microflora obviously during processing. The development of lactic acid bacteria generates a fresh meat item in milk, brined vegetables, many cereal products and meats with extra carbohydrates. In raw meat and fish that are stored in a vacuum or in an environment with a high concentration of carbon dioxide, lactic acid bacteria are the dominant population and preserve the meat with a “hidden” fermentation.
- Growing healthcare expenses is driving the growth of the market
- Increasing investments in R&D is boosting the growth of the market
- Advancements in Biobanking and increasing trend in the conservation of cord blood stem cells for newborns is propelling the growth of the market
- Regenerative medicine breakthroughs is contributing to the growth of the market
- Biopreservation Media
- Nutrient Media
- Growth Factors and Supplements
- Biopreservation Equipment
- Temperature Control Systems
- Cryogenic Storage Systems
- Thawing Equipment
- Alarms & Monitoring Systems
- Other Equipment
- Temperature Control Systems
- Human Tissue Samples
- Stem Cells
- Other Biospecimens
- Therapeutic Applications
- Research Applications
- Clinical Trials
- Other Applications
By End User
- Gene Banks
- Other End Users
Key Developments in the Market:
- In June 2019 At IFT 2019, Royal DSM is presenting its full range of Biopreservation alternatives. DSM’s variety allows dairy, beverage and baking producers to effectively combat spoilage while preserving the high-quality texture and flavor expected by customers. DSM is a breakthrough in bio-protection and anti-oxidant alternatives and has a wide range of products for milk, bakery and beverages.
- In March 2019 Thermo Fisher Scientific has committed to the acquisition of Brammer Bio. This agreement was intended to improve the involvement of the purchaser in the creation of the viral vector agreement and manufacturing organization (CDMO) gene therapy. The purchase of Brammer Bio’s viral vector skills with its GMP manufacturing knowledge and proprietary bioprocessing and cell culture techniques exclusively position us to engage with our clients to fuel the evolution of this extremely fast-growing industry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
North America Biopreservation Market By Product ( Biopreservation Media, Biopreservation Equipment), Biospecimens ( Human Tissue Samples, Organs, Stem Cells, Other Biospecimens) Application ( Therapeutic Applications, Research Applications, Clinical Trials, Other Applications), End User ( Biobanks, Gene Banks, Hospitals, Other End Users), Country (U.S., Canada, Mexico) – Industry Trends and Forecast to 2026
North America biopreservation market is registering a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. The rise in the market can be attributed due to growing healthcare expenses, increasing investments in R&D, Advancements in Biobanking and increasing trend in the conservation of cord blood stem cells for newborns